Harpoon Therapeutics captures $45M for cancer therapies South San Francisco-based biotech startup Harpoon Therapeutics, which is developing T-cell recruiting biologic therapies for the treatment of cancer,has raised $45Min a Series B funding round. The funding was led by Arix Bioscience and New Leaf Venture Partners, and also included Arix Bioscience, New Leaf Venture Partners, Taiho Ventures, and MPM Capital.(Silicontap)